Sharps Technology Raises $400 Million in Private Placement and Launches Crypto Treasury Strategy
August 29, 2025 – New York – Sharps Technology, a New York-based medical device and pharmaceutical packaging company known for its smart safety syringe products, announced the successful closing of a private placement worth over $400 million. The company also revealed plans to establish a digital asset treasury strategy centered around the cryptocurrency Solana (SOL).
Details of the Private Placement
Sharps Technology offered common stock and stapled warrants at a purchase price of $6.50 per unit in its recent private placement offering. The initial closing generated proceeds exceeding $400 million. Should all warrants be exercised, the company stands to raise an additional $600 million, bringing the potential total to $1 billion.
Currently, Sharps Technology’s shares trade on the NASDAQ under the ticker symbol STSS, with a market price near $14.40 per share.
Strategic Use of Funds: Launching a Solana-Based Digital Treasury
The company disclosed that the majority of the raised capital will be allocated toward acquiring the cryptocurrency SOL, the native digital asset of the Solana blockchain. This move aims to advance Sharps Technology’s digital treasury operations, positioning the firm to benefit from blockchain technology’s expanding utility in global finance.
The launch of this crypto treasury is supported by a non-binding letter of intent between Sharps Technology and the Solana Foundation. According to this agreement, Sharps will acquire $50 million worth of SOL at a 15% discount off a 30-day time-weighted average price. At the time of announcement, SOL was trading at approximately $209.46, a decline from its January peak of around $295. Alice Zhang, Chief Investment Officer and board member at Sharps Technology, emphasized the company’s confidence in the strategy: “Solana is capable of handling any tradable asset, everywhere in the world and demand is only increasing. With the backing of premier financial and digital asset investors, we believe we are well equipped to execute on our vision with our team’s extensive experience in the Solana ecosystem.”
Additional funds from the offering will be used for working capital and other general corporate purposes.
Prominent Investors Back the Deal
The private placement attracted a diverse group of investors, including financial institutions and digital asset firms such as Bastion Trading, ParaFi, FalconX, Pantera, Monarq, RockawayX, Saba Capital, Syncracy, Arche Capital, and Arrington Capital.
Context: Cryptocurrency Moves in MedTech Investments
Sharps Technology’s entry into digital asset management reflects a broader trend among medical technology companies increasingly adopting cryptocurrency for investment and corporate treasury functions.
Earlier this year, fintech affiliate Goldeneye 1995 LLC, linked to Ripple’s former Chief Risk Officer Greg Kidd, acquired a controlling interest in Know Labs—a U.S.-based health monitoring company—using 1,000 Bitcoin valued at the time at over $105,000 per coin. Know Labs develops innovative non-invasive health monitoring tools based on radio-microwave spectroscopy. This acquisition underscored growing interest in integrating digital currencies within healthcare finance and investment.
Looking Ahead
As the convergence of blockchain technology and healthcare continues to evolve, Sharps Technology’s move positions it at the forefront of medtech companies leveraging digital assets to diversify their financial strategies and enhance operational capabilities.
For more coverage on cryptocurrency and healthcare technology, visit MobiHealthNews.